VeriMomcymbopogon citratus leaf extract oxidized est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment indicating reproductive hazard for CAS 84238-19-7 was identified. PubMed/CosIng searches do not reveal ingredient-specific reproductive toxicity data. Topical cosmetic use may lead to low but measurable systemic exposure due to volatile constituents (e.g., citral), so exposure scored as low (1). Sources consulted: ECHA Annex VI (no harmonised hazard), PubChem/CosIng entries, PubMed (no ingredient-specific repro studies), EWG (ingredient profile).
Related ingredients
Frequently asked questions
- cymbopogon citratus leaf extract oxidized est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment indicating reproductive hazard for CAS 84238-19-7 was identified. PubMed/CosIng searches do not reveal ingredient-specific reproductive toxicity data. Topical cosmetic use may lead to low but measurable systemic exposure due to volatile constituents (e.g., citral), so exposure scored as low (1). Sources consulted: ECHA Annex VI (no harmonised hazard), PubChem/CosIng entries, PubMed (no ingredient-specific repro studies), EWG (ingredient profile).
- cymbopogon citratus leaf extract oxidized est-il sûr pendant l'allaitement ?
- No evidence of reproductive or lactation-specific toxicity for this ingredient in authoritative assessments. Systemic transfer into breastmilk is theoretical but not demonstrated for this extract; exposure scored as low (1) given potential for low systemic absorption of volatile constituents with topical use. Sources: ECHA Annex VI, PubChem, CosIng, PubMed (no specific studies).
- cymbopogon citratus leaf extract oxidized est-il sûr pour la peau de bébé ?
- No infant-specific toxicity data were found and no harmonised reproductive/ developmental classification applies. Because infant skin has higher permeability and surface-area-to-weight ratio and lemongrass extracts can contain absorbable volatile constituents (e.g., citral), exposure was increased by +1 for 0–3 yr (adult exposure low → infant moderate). Note: primary concern for topical use is skin sensitization (citral), not documented developmental toxicity for this extract. Sources: CosIng, PubChem, PubMed, EWG, ECHA (no harmonised classification).
- Comment VeriMom évalue-t-il cymbopogon citratus leaf extract oxidized ?
- VeriMom évalue cymbopogon citratus leaf extract oxidized à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à cymbopogon citratus leaf extract oxidized pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à cymbopogon citratus leaf extract oxidized basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.